Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04084834
Other study ID # 2018/2198-feasibility
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 9, 2019
Est. completion date June 1, 2020

Study information

Verified date September 2022
Source Diakonhjemmet Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In this project, a web-based exercise program is developed in co-creation between specialized health care, the Norwegian Association for Rheumatic diseases (NRF) and a group of experienced patient representatives. The project emerges from the evidence that exercise is recommended as first-line treatment for patients with chronic diseases like hip- and knee-osteoarthritis (OA). However, the number of patients in need of targeted exercise will increase considerably the next decades, and their treatment needs cannot be fully handled within the health care system. Development of innovative and effective treatment trajectories and follow-up strategies is urgently required. Peer-support is recognized as an effective way to increase patients' long-term adherence to exercise. Thus, patient-organizations may be an unutilized resource in support and follow-up of patients who need long-term exercise as part of their treatment plan. After discharge from examination in hospital, patients with hip/knee OA will be recruited to follow-up in a novel web-based, peer-supported exercise program, and the feasibility of the intervention will be evaluated.


Description:

The study will be conducted as a pre-post single-arm feasibility study comprising 50 participants. The main objective of the study will be to evaluate the feasibility of the web-based, peer-supported exercise intervention in patients with hip and/or knee OA. Specific research objectives are: - to assess feasibility of intervention delivery, data collection, eligibility and inclusion/exclusion criteria and intervention fidelity - to assess the responsiveness of relevant primary and secondary outcome measures In the feasibility study, all participants will be allocated to an intervention group, receiving a 12-week web-based, peer-supported aerobic exercise program including weekly motivational messages. Patients between 40 and 80 years of age that are not candidates for surgery will be recruited from Diakonhjemmet Hospital, Oslo, Norway. To assess and evaluate feasibility, we will report on descriptive statistics. Responsiveness will be assessed using Receiver Operating Curve (ROC) analyses.


Recruitment information / eligibility

Status Completed
Enrollment 31
Est. completion date June 1, 2020
Est. primary completion date June 1, 2020
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria: • patients with hip and/or knee osteoarthritis being referred to Diakonhjemmet Hospital Exclusion Criteria: - candidate for surgery - unable to understand or write Norwegian - unable to walk unaided and continuously for 15 minutes - absolute or relative contradictions to maximal exercise testing - have relatives with sudden death before 40 years of age - have first-degree relatives with hypertrophic cardiomyopathy

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Exercise
Participants will be offered to take part in a 5-hour Learning and Mastery-course at Diakonhjemmet Hospital, receiving information about the osteoarthritis disease, symptoms and the importance of exercise and physical activity. Participants will then be given a weekly web-based exercise program (12 weeks) consisting of three aerobic exercise sessions per week. The exercise program consists of five levels, and the participants will each week be guided to the most appropriate level based on their measured physical fitness level and the weekly exercise diary. The participants will at initial assessment at Diakonhjemmet Hospital be instructed to use Borgs scale to adjust exercise level. Based on the weekly exercise diary the participants will also get motivational messages by email.

Locations

Country Name City State
Norway Diakonhjemmet Hospital Oslo

Sponsors (4)

Lead Sponsor Collaborator
Diakonhjemmet Hospital Extrastiftelsen, The Norwegian Rheumatism Association, University of Melbourne

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other Participant fidelity: proportion attending learning and mastery-course Proportion of enrolled participants attending a 5-hour osteoarthritis learning and mastery-course (attendance registered by yes/no). baseline to 12 weeks
Other Participant fidelity (adherence): frequency of exercise Total number of exercise sessions. baseline to 12 weeks
Other Participant fidelity (adherence): frequency of exercise per week Average number of exercise sessions per week. baseline to 12 weeks
Other Participant fidelity (adherence): frequency of exercise weeks Total number of weeks with minimum one exercise session. baseline to 12 weeks
Other Participant fidelity (adherence): duration of exercise sessions Total number of exercise sessions completed according to prescribed duration. Measured by a question about completion of the prescribed exercise-session (yes/no). baseline to 12 weeks
Other Participant fidelity (adherence): intensity of exercise sessions Total number of exercise sessions completed according to prescribed intensity. Measured by self-reported Rating of Perceived Exertion Scale (Borg RPE) ranging from 6 (resting) to 20 (maximal intensity). baseline to 12 weeks
Other Use of health care resources due to musculoskeletal pain Registered by self-report: 1) frequency (number of consultations the last 6 months) with a general practitioner and specialist health care (rheumatologist, orthopedist, neurologist, other), 2) referred (yes/no, the last 6 months) to x-ray, magnetic resonance imaging, physiotherapist, healthy life center, occupational therapist, 3) frequency (number of consultations during the last 6 months) with a physiotherapist, manual therapist, chiropractor, alternative treatment, other due, 4) had a stay at a rehabilitation institution during the last 6 months (yes/no and number of days). Descriptive data will be reported. baseline
Other Use of medication due to musculoskeletal pain Registered by self-report: Frequency (never/<1 per month/monthly/weekly/daily/several times per day) of medication use (addressing pain, sleeping, depression, anxiety) the last 3 months will be self-reported through type, name and dosage (mg) of medication, in addition to use of other medication (yes/no) and type. Descriptive data will be reported. baseline
Other Osteoarthritis pain on a Global Rating of Change scale Change in osteoarthritis pain (from baseline to post-test) measured by a 7-point Global Rating of Change scale ranging from -3 (much worse) to +3 (much better). 12 weeks
Primary Feasibility: time resources used by peer-supporters Time (hours/minutes) per participant-peer-support contact (frequency of contacts divided by total time used by peer-supporters). baseline to 12 weeks
Primary Feasibility: time resources used on the exercise program delivery Time (hours/minutes) per week per participant used on web-based exercise program delivery. baseline to 12 weeks
Primary Feasibility: time resources used on motivational messages delivery Time (hours/minutes) per week per participant used on motivational message delivery. baseline to 12 weeks
Primary Feasibility: proportion of received exercise diaries Proportion of received exercise diaries (0-12 per participant). baseline to 12 weeks
Primary Feasibility: proportion wearing the activity monitor Proportion of participants providing activity monitor data (at least 4 days, including one weekend day, with minimum 10 hours recording per day) at baseline. baseline
Primary Feasibility: proportion completing treadmill test Proportion of participants completing the indirect maximal cardiorespiratory exercise test according to test-protocol at baseline. baseline
Primary Eligible: proportion eligible Proportion of potentially eligible participants approached that are invited. baseline
Primary Recruitment: proportion enrolled Proportion of eligible patients enrolled. baseline
Primary Retention: proportion of enrolled participants Proportion of enrolled participants providing data at 12 week post-test. baseline and 12 weeks
Primary Adverse events: number of adverse events Total number of adverse events (by cause if possible) evaluated by answers at post-test: The four questions addressing possible adverse events: 1) Have you carried out any type of treatment during the last 3 months? (With treatment we mean medication, physical exercise, self-management course or any alternative treatments) (yes/no), 2) If yes, have you experienced any adverse event as a result of the treatment? (yes/no). 3) If yes, which adverse events as a result of treatment? 4) In your opinion, which treatment(s) do you think the adverse event was/were caused by? (medication, physical exercise, self-management course, alternative treatments, other) (Elaborate). 12 weeks
Secondary Changes in objectively measured physical activity Assessed by accelerometer (ActiGraph GT3X+): Change in physical activity level measured as counts per minute (CPM), which is the total number of registered counts for all valid days divided by wear time. Thresholds for CPM will be used in calculation of time (minutes per week/day) spent on sitting (<100 CPM), and on light (100-2019 CPM), moderate-(>2019-5998 CPM) and vigorous (>5998) intensity physical activity. baseline and 12 weeks
Secondary Change in physical fitness (VO2 peak) Change in VO2 peak measured by indirect maximal cardiorespiratory exercise test (modified Balke-protocol). The indirect estimation of VO2 peak by prediction equations is based on incline, grade and speed at end stage, weight and age. baseline and 12 weeks
Secondary Change in Hip disability and Osteoarthritis Outcome Score (HOOS) Change in the last week disability on five subscales; pain (10 items, scale 0-40), symptoms (5 items, scale 0-20), function in daily living (17 items, scale 0-68), function in sport and recreation (4 items, scale 0-16) and quality of life (4 items, scale 0-16). Items are scored by a five-point Likert scale ranging from 0 (least severe) to 4 (most severe). Total sum-score and subscale sum-scores will be converted to normalized scores ranging from 0 (extreme disability) to 100 (no disability). baseline and 12 weeks
Secondary Change in Knee disability and Osteoarthritis Outcome Score (KOOS) Change in the last week disability on five subscales; pain (9 items, scale 0-36), symptoms (7 items, scale 0-28), function in daily living (17 items, scale 0-68), function in sport and recreation (5 items, scale 0-20) and quality of life (4 items, scale 0-16). Items are scored by a five-point Likert scale ranging from 0 (least severe) to 4 (most severe). Total sum-score and subscale sum-scores will be converted to normalized scores ranging from 0 (extreme disability) to 100 (no disability). baseline and 12 weeks
Secondary Change in Patient-specific functional scale (PSFS) Patients will address one to three activities they have problems performing due to osteoarthritis. The degree of difficulty with performing these activities is rated from 0 (cannot perform the activity) to 10 (no problems). baseline and 12 weeks
Secondary Change in self-reported physical activity (International Physical Activity Questionnaire-Short Form) Measured by The International Physical Activity Questionnaire-Short Form: Change in time (minutes per week/day) and Metabolic Equivalent of Task (MET-minutes per week/day) spent on sitting, walking, and moderate- and vigorous intensity physical activity the last week (0-7 days). METs are calculated by using the corresponding MET-values for walking (3.3 MET), and moderate-(4.0 MET) and vigorous (8.0 MET) intensity physical activity. baseline and 12 weeks
Secondary Change in self-reported physical activity (HUNT) Measured by the three questions from the Nord-Trøndelag Health study (HUNT): change in average frequency (never/<1 per week/1 per week/2-3 per week/almost every day), intensity (easy without losing my breath or breaking into a sweat/so hard that I lose my breath and break into a sweat/I push myself to near-exhaustion) and duration (less than 15 minutes/15-29 minutes/30 minutes to 1 hour/more than 1 hour) of physical activity. baseline and 12 weeks
Secondary Change in self-reported pain intensity the last week Measured by numeric rating scale ranging from 0 (no pain) to 10 (worst pain). baseline and 12 weeks
Secondary Change in self-reported fatigue the last week Measured by numeric rating scale ranging from 0 (no fatigue) to 10 (worst fatigue). baseline and 12 weeks
Secondary Change in self-reported disease activity the last week Measured by numeric rating scale ranging from 0 (good, no symptoms) to 10 (very bad, much symptoms). baseline and 12 weeks
Secondary Change in Health-related quality of life (EQ-5D-5L) EQ-5D-5L will be used for measuring health-related quality of life (www.euroqol.org): comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each dimension has five levels of answers (no problems, slight problems, moderate problems, severe problems, and extreme problems). The average score on each dimension will be reported, and the total score can be calculated into an index value ranging from -0.59 to 1, where -0.59 represents worst possible state and 1 represents perfect health. baseline and 12 weeks
Secondary Change in Arthritis Self-Efficacy Scale (ASES) Measured by Arthritis Self-Efficacy Scale (ASES): comprises 11 items addressing pain and symptoms (scored on a 5-point scale ranging from not confident at all to very confident). The scores are summed up to a 0-100 score where higher score indicate better self-efficacy. baseline and 12 weeks
Secondary Change in exercise self-efficacy Measured by Exercise Beliefs and Exercise Habits questionnaire: comprises 20 items addressing exercise self-efficacy (4 items), barriers to exercise (3 items), benefits of exercise (5 items), and impact of exercise on arthritis (8 items), scored on a 5-point Likert scale ranging from strongly disagree to strongly agree. The scores on each subscale is summed up where higher scores indicate better self-efficacy. baseline and 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03895489 - Effectiveness of the Journey Total Knee Arthroplasty Versus Two Standard of Care Total Knee Arthroplasty Prostheses N/A
Completed NCT03660943 - A Clinical Study to Test Efficacy and Safety of Repeat Doses of CNTX-4975-05 in Patients With Osteoarthritis Knee Pain Phase 3
Completed NCT04531969 - Comparison of Outpatient and Inpatient Spa Therapy N/A
Completed NCT02848027 - Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx®SD Treatment Phase 3
Completed NCT05160246 - The Instant Effect of Kinesiology Taping in Patients With Knee OA N/A
Recruiting NCT06080763 - Biomechanics and Clinical Outcomes in Responders and Non-Responders
Completed NCT03643588 - The Comparison of HYAJOINT Plus and Hyalgan Hyaluronan Supplement for Knee Osteoarthritis Pain N/A
Active, not recruiting NCT05100225 - Efficacy and Safety Trial of PTP-001 (MOTYS) for Symptomatic Knee Osteoarthritis Phase 2
Active, not recruiting NCT04061733 - New Hydroxyethyl Cellulose Hydrogel for the Treatment of the Pain of Knee Arthrosis N/A
Completed NCT04051489 - A Novel Smartphone Application for "Smart" Knee Osteoarthritis Trials
Recruiting NCT05546541 - Epidemiology and Nutrition
Recruiting NCT05447767 - Prediction AlgoriThm for regeneraTive Medicine Approach in knEe OA: New Decision-making Process Based on Patient pRofiliNg Phase 2
Not yet recruiting NCT04448106 - Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for Osteoarthritis Phase 2
Not yet recruiting NCT03225911 - Effect of a Lateral Wedge Insole and Simple Knee Sleeve in Individuals With Knee Osteoarthritis N/A
Completed NCT05070871 - A Clinical Trial Investigating the Effect of Salmon Bone Meal on Osteoarthritis Among Men and Women N/A
Completed NCT05703087 - Positive Cueing in Knee Arthroplasty. N/A
Not yet recruiting NCT06042426 - Effects of Perioperative Intravenous Dexamethasone in Clinical Outcomes After Total Knee Arthroplasty in a Hispanic Population Phase 4
Terminated NCT02615522 - Prospective Post Market Clinical Follow-Up of the Primary Knee Endoprosthesis BPK-S Integration
Terminated NCT02909257 - Motor-Sparing Femoral Nerve Block Dose Phase 4
Completed NCT02944448 - A Study Evaluating Pain Relief and Safety of Orally Administered CR845 in Patients With Osteoarthritis of Hip or Knee Phase 2